LONATI, PAOLA ADELE
LONATI, PAOLA ADELE
Universita' degli Studi di MILANO
Production of anti-{PF}4 antibodies in antiphospholipid antibody-positive patients is not affected by {COVID}-19 vaccination
2022 P.A. Lonati, C. Bodio, M. Scavone, G. Martini, E. Pesce, A. Bandera, A. Lombardi, M. Gerosa, F. Franceschini, A. Tincani, G. Podda, S. Abrignani, R. Grifantini, M.N. Cattaneo, M.O. Borghi, P. Luigi Meroni
Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases
2022 S. Cavalli, P.A. Lonati, M. Gerosa, R. Caporali, R. Cimaz, C.B. Chighizola
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
2022 M.O. Borghi, M. Bombaci, C. Bodio, P.A. Lonati, A. Gobbini, M. Lorenzo, E. Torresani, A. Dubini, I. Bulgarelli, F. Solari, F. Pregnolato, A. Bandera, A. Gori, G. Parati, S. Abrignani, R. Grifantini, P.L. Meroni
Histone deacetylase inhibitors ameliorate morphological defects and hypoexcitability of iPSC-neurons from Rubinstein-Taybi patients
2021 V. Alari, P. Scalmani, P.F. Ajmone, S. Perego, S. Avignone, I. Catusi, P.A. Lonati, M.O. Borghi, P. Finelli, B. Terragni, M. Mantegazza, S. Russo, L. Larizza
Complement activation and endothelial perturbation parallel COVID-19 severity and activity
2021 M. Cugno, P.L. Meroni, R. Gualtierotti, S. Griffini, E. Grovetti, A. Torri, P. Lonati, C. Grossi, M.O. Borghi, C. Novembrino, M. Boscolo, S.C. Uceda Renteria, L. Valenti, G. Lamorte, M. Manunta, D. Prati, A. Pesenti, F. Blasi, G. Costantino, A. Gori, A. Bandera, F. Tedesco, F. Peyvandi
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis
2020 E. Raschi, D. Privitera, C. Bodio, P.A. Lonati, M.O. Borghi, F. Ingegnoli, P.L. Meroni, C.B. Chighizola
Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome
2019 P.A. Lonati, M. Scavone, M. Gerosa, M.O. Borghi, F. Pregnolato, D. Curreli, G. Podda, E.A. Femia, W. Barcellini, M. Cattaneo, F. Tedesco, P.L. Meroni
Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications
2018 F. Tedesco, M.O. Borghi, M. Gerosa, C.B. Chighizola, P. Macor, P.A. Lonati, A. Gulino, B. Belmonte, P.L. Meroni
Primary Antiphospholipid Syndrome Patients Display Increased Levels of Cell-Bound C4d in Comparison to SLE and Healthy Donors
2015 M. Gerosa, P.A. Lonati, T. Ubiali, M. Cornalba, M.O. Borghi, P. Meroni
LOCALIZZAZIONE E QUANTIFICAZIONE DELLE ISOFORME DELL'INTERLEUCHINA 17 NEL DERMA DI PAZIENTI AFFETTI DA PATOLOGIE FIBROSANTI CUTENAEE
2013 P.A. Lonati
Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement
2013 M. Truchetet, N. Brembilla, E. Montanari, P. Lonati, E. Raschi, S. Zeni, L. Fontao, P. Meroni, C. Chizzolini
LIN7 regulates the filopodia and neurite promoting activity of IRSp53
2012 A. Crespi, I. Ferrari, P. Lonati, A. Disanza, D. Fornasari, G. Scita, V. Padovano, G. Pietrini